Biology and Treatment of Paget's Disease of Bone
- PMID: 26212817
- DOI: 10.1002/jcb.25291
Biology and Treatment of Paget's Disease of Bone
Abstract
Paget's disease of bone (PDB) is a common skeletal disorder characterized by increased and disorganized bone remodeling affecting one or more skeletal sites. Although some patients are asymptomatic others develop complications such as bone pain, deformity, nerve compression syndromes, and fragility fractures. Genetic factors play an important role in the pathogenesis of PDB and there is strong evidence that susceptibility is determined by variants within or close to genes that regulate osteoclast function. Environmental factors also play a key role but the nature of the environmental triggers is less clear. Bisphosphonates are a highly effective treatment for the elevations in bone turnover that are characteristic of PDB but it is unclear at present if they alter the natural history of the disease. Here, we review the epidemiology, clinical, cellular, and molecular abnormalities in PDB as well as environmental and genetic triggers, and current available treatment options.
Keywords: BISPHOSPHONATES; BONE DISEASE; PAGET'S DISEASE.
© 2015 Wiley Periodicals, Inc.
Similar articles
-
Pathogenesis of Paget's disease of bone.Bone. 2008 Nov;43(5):819-25. doi: 10.1016/j.bone.2008.06.015. Epub 2008 Jul 11. Bone. 2008. PMID: 18672105 Review.
-
Paget's disease of bone.QJM. 2014 Nov;107(11):865-9. doi: 10.1093/qjmed/hcu075. Epub 2014 Apr 21. QJM. 2014. PMID: 24757095 Review.
-
Paget's disease of bone.Metabolism. 2018 Mar;80:5-14. doi: 10.1016/j.metabol.2017.06.010. Epub 2017 Jul 4. Metabolism. 2018. PMID: 28780255 Review.
-
Paget's Disease of Bone.Calcif Tissue Int. 2019 May;104(5):483-500. doi: 10.1007/s00223-019-00522-3. Epub 2019 Jan 23. Calcif Tissue Int. 2019. PMID: 30671590 Review.
-
Diagnosis and treatment of Paget's disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS).J Endocrinol Invest. 2024 Jun;47(6):1335-1360. doi: 10.1007/s40618-024-02318-1. Epub 2024 Mar 15. J Endocrinol Invest. 2024. PMID: 38488978 Free PMC article. Review.
Cited by
-
Sphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potential.Expert Opin Ther Targets. 2017 Jul;21(7):725-737. doi: 10.1080/14728222.2017.1332180. Epub 2017 Jun 7. Expert Opin Ther Targets. 2017. PMID: 28524744 Free PMC article. Review.
-
Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.Adv Exp Med Biol. 2019;1148:279-322. doi: 10.1007/978-981-13-7709-9_13. Adv Exp Med Biol. 2019. PMID: 31482504 Review.
-
Spinal Paget's disease with bilevel cord compression and ischemic non-compressive myelopathy treated with zoledronic acid.Clin Case Rep. 2022 Aug 18;10(8):e6263. doi: 10.1002/ccr3.6263. eCollection 2022 Aug. Clin Case Rep. 2022. PMID: 35999985 Free PMC article.
-
Molecular insights into an ancient form of Paget's disease of bone.Proc Natl Acad Sci U S A. 2019 May 21;116(21):10463-10472. doi: 10.1073/pnas.1820556116. Epub 2019 Apr 29. Proc Natl Acad Sci U S A. 2019. PMID: 31036632 Free PMC article.
-
Epidemiology and pathology of Paget's disease of bone - a review.Wien Med Wochenschr. 2017 Feb;167(1-2):2-8. doi: 10.1007/s10354-016-0496-4. Epub 2016 Sep 6. Wien Med Wochenschr. 2017. PMID: 27600564 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical